Clinical trial

Bioequivalence Study of BGM0504 Injection

NCT07382908

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-12-23

PhasePHASE1

Study timeline

Study start (actual)2025-12-23Date precision: day

Registry last updated2026-02-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Overweight/Obesityunresolved

Interventions

BGM0504 Injection multi-dose penDRUG

BGM0504 Injection single-dose penDRUG

Sponsors & collaborators

BrightGene Bio-Medical Technology Co., Ltd.lead sponsor

BrightGene Pharmaceutical Co., Ltd.collaborator

Mapped research locations

HangzhouZhejiang, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07382908 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.